Oral vs Topical Minoxidil: Which Works for Hair Loss?

Why is minoxidil being discussed alongside GLP-1 medicines?

In a September 3 announcement, NYU Langone researchers suggested that future investigations could explore adding treatments such as minoxidil for some people taking GLP-1 medicines. Their analysis examined genetic evidence related to GLP-1 receptor activity and male pattern hair loss. It did not assign patients to weight-loss drugs or test a hair-protection regimen. Preventive combination treatment therefore remains a research proposal, rather than a demonstrated benefit of the study. [NYU Langone announcement](https://nyulangone.org/news/some-hair-loss-men-linked-use-weight-loss-drugs)

The diagnosis matters because hair shedding after substantial weight loss can differ from inherited pattern baldness. The American Academy of Dermatology describes telogen effluvium as excessive shedding that can follow physical stress and often improves as the body recovers. Hereditary hair loss may progress without treatment, and both conditions can coexist. A dermatologist can distinguish these possibilities before deciding whether a medicine is appropriate. [AAD guidance on hair shedding](https://www.aad.org/public/diseases/hair-loss/insider/shedding)

Does oral minoxidil work better than topical minoxidil?

A trial published in JAMA Dermatology in 2024 enrolled 90 men with androgenetic alopecia. It compared oral minoxidil, 5 mg daily, with topical minoxidil, 5%, twice daily for 24 weeks. Oral treatment did not demonstrate overall superiority, although photographic assessment favored it at the crown. These findings do not prove that the two treatments are equivalent. [Randomized minoxidil trial](https://jamanetwork.com/journals/jamadermatology/fullarticle/2817326)

The study was small, conducted at one center, and affected by participant loss during follow-up. It addressed male pattern baldness, rather than prevention of GLP-1-associated shedding. Its findings therefore cannot establish that either formulation protects hair during weight-loss treatment. Larger, longer studies in the relevant patients would be needed to answer that question. [Trial findings and limitations](https://jamanetwork.com/journals/jamadermatology/fullarticle/2817326)

What should patients consider before starting minoxidil?

Oral minoxidil is used off-label for hair loss; its labeled indication is severe hypertension that has not responded adequately to other treatment. Because it acts throughout the body, prescribing requires attention to cardiovascular effects. The tablet label warns about fluid retention, increased heart rate, and fluid accumulation around the heart. Those warnings come from its antihypertensive use and do not establish the frequency of these complications at lower doses used for hair loss. [Minoxidil tablet prescribing information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=637718aa-a453-4acd-a992-590d637b63a3)

Topical minoxidil is applied to the scalp and can help some people with early hair loss. According to the American Academy of Dermatology, visible results commonly take six to twelve months, and continued application is needed to maintain its benefits. An assessment may also identify another contributor, such as a nutritional deficiency or hormonal disorder. Treatment can then address the cause instead of assuming every episode of shedding requires another medicine. [AAD diagnosis and treatment guidance](https://www.aad.org/public/diseases/hair-loss/treatment/diagnosis-treat)